SENS-AI
BTI Director Dealings Neutral

BRITISH AMERICAN TOBACCO PLC - Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

British American Tobacco p.l.c.
Full analysis

What this filing means

BAT's CEO Tadeu Marroco received 377 ordinary shares at £42.14 each under the group's Deferred Share Bonus Scheme — a scheduled quarterly dividend-equivalent allocation rather than an open-market purchase. The transaction settled outside a trading venue and totalled £15,886.78, a trivial sum against BAT's roughly R2.2 trillion market cap. The naming of a single PDMR with no corroborating insider activity, on a name whose share has sold off 17% in the 20 trading days before the announcement, does not change what this filing is: mechanical scheme paperwork that contributes nothing to that drift.

A filing like this can look at first glance like the CEO is putting his hand in his pocket and backing the company. He is not. The 377 shares are paid out by the company's own bonus scheme as a quarterly dividend-equivalent top-up — that is his compensation, not a personal capital decision. So the only thing this announcement tells the reader is that BAT is honouring its scheme on schedule. It carries no insider-buying signal worth reacting to.

Bear case

  • Transaction is a scheduled Deferred Share Bonus Scheme allocation, not a discretionary buy — provides no incremental insider-conviction signal.
View original SENS announcement

AI-generated summary by SENS-AI, based on the original JSE SENS filing.

SENS-AI conclusion

Mechanical scheme paperwork, not insider conviction. The 377 shares are a quarterly dividend-equivalent allocation under an existing Deferred Share Bonus Scheme, settled outside a trading venue — Marroco never chose to deploy personal capital into the open market, and the value is too small to register as a signal even if he had. The filing also names only one PDMR with no corroborating insider activity. CAR-20 of -17% is unrelated context: a scheduled scheme settlement carries no information that could move it, in either direction. So what: there is nothing here to act on; the next useful disclosure will be whatever next updates BAT's operating story. Missing evidence: Filing does not disclose CEO's total beneficial holding or percentage change; No disclosure of whether shares are subject to further vesting or holding periods; No context on whether this is part of normal quarterly cycle or exceptional adjustment; No information on CEO's personal wealth or whether this represents material economic commitment; Filing does not state whether closed period rules were considered or clearance obtained; No comparison to prior quarterly dividend-equivalent awards provided

The next operational update is where the market will reassess BAT's forward trajectory; this filing does not move that.

Evidence from the filing

  • Transaction is a scheduled Deferred Share Bonus Scheme allocation, not a discretionary buy — provides no incremental insider-conviction signal.

    “Acquisition of quarterly dividend equivalent shares under the British American Tobacco Deferred Share Bonus Scheme”
Category
Director Dealings
Event posture
No Edge
Published
Aug 18, 2026

More on British American Tobacco p.l.c.

British American Tobacco p.l.c. (BTI) share price All British American Tobacco p.l.c. SENS announcements

Related filings